The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma
Portal vein tumor thrombosis (PVTT), a severe complication of hepatocellular carcinoma (HCC), markedly influences patient prognosis by fostering a hypercoagulable state. However, its molecular underpinnings remain largely unexplored. This study sheds light on the critical role of the KIT ligand (KIT...
Saved in:
Main Authors: | Feifei Mao (Author), Yuqiang Cheng (Author), Kang Wang (Author), Zongtao Chai (Author), Lei Guo (Author), Yanyan Xu (Author), Xue Chen (Author), Jie Shi (Author), Weixing Guo (Author), Junling Liu (Author), Shuqun Cheng (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation
by: Jianbo Wang, et al.
Published: (2021) -
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain
by: Elena Gabriele, et al.
Published: (2017) -
Kit ligand promotes first polar body extrusion of mouse preovulatory oocytes
by: Ye Yinghui, et al.
Published: (2009) -
Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
by: Qian Ren, et al.
Published: (2022) -
Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating Smad2/3 pathway in colorectal cancer
by: Gui Hu, et al.
Published: (2023)